Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Firebrick Pharma Limited ( (AU:FRE) ).
Firebrick Pharma Limited has applied for quotation on the ASX of 10,638,297 ordinary fully paid shares under code FRE, with an issue date of 17 April 2026. The move increases the number of tradeable securities on market, potentially enhancing liquidity for investors and supporting the company’s capital structure as it progresses its pharmaceutical activities.
The application reflects a previously announced issuance of securities and formalises their admission to trading on the exchange. This step may strengthen Firebrick Pharma’s presence in the public markets and could facilitate broader shareholder participation as the company advances its strategic and operational objectives.
More about Firebrick Pharma Limited
Firebrick Pharma Limited, listed on the ASX under the ticker FRE, operates in the pharmaceutical sector. The company focuses on developing and commercialising healthcare products, positioning itself within the broader life sciences and medical markets.
Average Trading Volume: 91,873
Technical Sentiment Signal: Buy
Current Market Cap: A$18.37M
For an in-depth examination of FRE stock, go to TipRanks’ Overview page.